|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/24/13 Organovo Holdings, Inc. 10-KT 3/31/13 66:7.4M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-KT Annual-Transition Report HTML 783K
2: EX-23.1 Consent of Experts or Counsel HTML 18K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
43: R1 Document and Entity Information HTML 48K
33: R2 Consolidated Balance Sheets HTML 129K
41: R3 Consolidated Balance Sheets (Parenthetical) HTML 33K
46: R4 Consolidated Statements of Operations HTML 83K
61: R5 Consolidated Statements of Stockholders' Equity HTML 134K
(Deficit)
35: R6 Consolidated Statements of Cash Flows HTML 156K
40: R7 Consolidated Statements of Cash Flows HTML 47K
(Parenthetical)
30: R8 Change in Fiscal Year End HTML 22K
22: R9 Description of Business and Summary of Significant HTML 96K
Accounting Policies
62: R10 Fixed Assets HTML 37K
48: R11 Accrued Expenses HTML 29K
47: R12 Derivative Liability HTML 49K
52: R13 Convertible Notes Payable HTML 39K
53: R14 Stockholders' Equity HTML 112K
51: R15 Commitments and Contingencies HTML 44K
54: R16 Licensing Agreements and Research Contracts HTML 37K
42: R17 Income Taxes HTML 43K
45: R18 Concentrations HTML 26K
50: R19 Subsequent Events HTML 22K
66: R20 Description of Business and Summary of Significant HTML 191K
Accounting Policies (Policies)
57: R21 Description of Business and Summary of Significant HTML 49K
Accounting Policies (Tables)
37: R22 Fixed Assets (Tables) HTML 35K
49: R23 Accrued Expenses (Tables) HTML 28K
39: R24 Derivative Liability (Tables) HTML 34K
16: R25 Stockholders' Equity (Tables) HTML 91K
58: R26 Commitments and Contingencies (Tables) HTML 40K
63: R27 Licensing Agreements and Research Contracts HTML 28K
(Tables)
26: R28 Income Taxes (Tables) HTML 35K
25: R29 Description of Business and Summary of Significant HTML 32K
Accounting Policies (Details)
28: R30 Description of Business and Summary of Significant HTML 38K
Accounting Policies (Details 1)
29: R31 Description of Business and Summary of Significant HTML 283K
Accounting Policies (Details Textual)
31: R32 Fixed Assets (Details) HTML 41K
15: R33 Fixed Assets (Details Textual) HTML 23K
55: R34 Accrued Expenses (Details) HTML 34K
36: R35 Derivative Liability (Details) HTML 34K
38: R36 Derivative Liability (Details Textual) HTML 39K
19: R37 Convertible Notes Payable (Details) HTML 230K
65: R38 Stockholders' Equity (Details) HTML 34K
12: R39 Stockholders' Equity (Details 1) HTML 59K
32: R40 Stockholders' Equity (Details 2) HTML 36K
60: R41 Stockholders' Equity (Details 3) HTML 49K
18: R42 Stockholders' Equity (Details 4) HTML 24K
24: R43 Stockholders' Equity (Details Textual) HTML 375K
27: R44 Commitments and Contingencies (Details) HTML 33K
34: R45 Commitments and Contingencies (Details 1) HTML 28K
14: R46 Commitments and Contingencies (Details 2) HTML 46K
21: R47 Commitments and Contingencies (Details Textual) HTML 34K
13: R48 Licensing Agreements and Research Contracts HTML 28K
(Details)
59: R49 Licensing Agreements and Research Contracts HTML 83K
(Details Textual)
17: R50 Income Taxes (Details) HTML 51K
56: R51 Income Taxes (Details Textual) HTML 48K
20: R52 Subsequent Events (Details Textual) HTML 29K
64: XML IDEA XML File -- Filing Summary XML 102K
23: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.16M
6: EX-101.INS XBRL Instance -- onvo-20130331 XML 1.38M
8: EX-101.CAL XBRL Calculations -- onvo-20130331_cal XML 193K
9: EX-101.DEF XBRL Definitions -- onvo-20130331_def XML 623K
10: EX-101.LAB XBRL Labels -- onvo-20130331_lab XML 1.38M
11: EX-101.PRE XBRL Presentations -- onvo-20130331_pre XML 981K
7: EX-101.SCH XBRL Schema -- onvo-20130331 XSD 201K
44: ZIP XBRL Zipped Folder -- 0001193125-13-235652-xbrl Zip 160K
| EX-31.1 |
Exhibit 31.1
CERTIFICATION
I, Keith Murphy, Chief Executive Officer and President of Organovo Holdings, Inc., certify that:
1. I have reviewed this transition report on Form 10-K of Organovo Holdings, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting
| Dated: May 24, 2013 | /s/ Keith Murphy | |||||
| Keith Murphy | ||||||
| Chief Executive Officer and President | ||||||
| (Principal Executive Officer) | ||||||
| This ‘10-KT’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/24/13 | |||
| For Period end: | 3/31/13 | 8-K | ||
| List all Filings | ||||